Leandro de Pádua Silva

Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome

Marcos de Lima, Sergio Giralt, Peter F. Thall et al. · Cancer · 2010 · 429 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Phase I Study of Epigenetic Modulation with 5-Azacytidine and Valproic Acid in Patients with Advanced Cancers

Fadi Braiteh, Andres O. Soriano, Guillermo Garcia‐Manero et al. · Clinical Cancer Research · 2008 · 165 citations · Full text

Medicine, Oncology, Pharmacology +16

Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth through Eighth Decades of Life

Gheath Alatrash, Marcos de Lima, Nelson Hamerschlak et al. · Biology of Blood and Marrow Transplantation · 2011 · 93 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease

Simrit Parmar, Marcos del Lima, Yizhou Zou et al. · Blood · 2009 · 83 citations · Full text

Life Sciences, Genetics, Immunology +17

Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD–Positive Acute Myelogenous Leukemia

Betül Oran, Jörge E. Cortes, Amer Beitinjaneh et al. · Biology of Blood and Marrow Transplantation · 2016 · 81 citations · Full text

Medicine, Oncology, Chemotherapy +13